帅心涛、魏波教授团队在Journal of Controlled release上发表最新研究成果
中大新闻网讯(通讯员丁东兵)近期,附属第三医院帅心涛、魏波教授团队在药剂学领域国际顶级学术期刊《Journal of Controlled release》(IF=10.8)上发表题为“Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer”的原创性研究成果。结肠癌的发病率目前仍呈上升趋势,是常见的消化道恶性肿瘤之一。肝转移是结肠癌最常见...



